Form 8-K - Current report:
SEC Accession No. 0001104659-20-090511
Filing Date
2020-08-05
Accepted
2020-08-05 06:10:31
Documents
2
Period of Report
2020-08-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K tm2026633-1_8k.htm 8-K 22730
2 GRAPHIC image_001.jpg GRAPHIC 1965
  Complete submission text file 0001104659-20-090511.txt   26726
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13341 | Film No.: 201075498
SIC: 2836 Biological Products, (No Diagnostic Substances)